Skip to content

Cumberland Pharmaceuticals CPIX Change in Other Assets

Change in Other Assets at other companies

Baxter International logo
Baxter InternationalBAX
-$2M-108%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$3.79M-71.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$18.85M+3,770%
RFL
Rafael Holdings, Inc.RFL
$360K+393%
Opko Health logo
Opko HealthOPK
-$6.97M-155%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$6.63M+119%

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+142%
Enterprise value$90.91M+212%
P/S2.3×+1.4×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's change in other assets?
Cumberland Pharmaceuticals (CPIX) reported change in other assets of -$384.15K in Q1 2026.
How has Cumberland Pharmaceuticals's change in other assets changed year-over-year?
Cumberland Pharmaceuticals's change in other assets decreased by 536.3% year-over-year, from -$60.37K to -$384.15K.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.